Multiple Myeloma Challenges and Treatment Evolution

Gabriel Hinojosa, PharmD, BCOP, explores unmet needs and social determinants in multiple myeloma care, envisioning treatment advancements amid evolving complexities and patient disparities.

Related Keywords

Gabriel Hinojosa , ,Multiple Myeloma ,Autologous Transplant ,Eligibility Factors ,Treatment Shifts ,Stem Cell Transplantation ,Myeloma Therapy ,Dvrd ,Pfas ,Griffin Trial ,Perseus Trial ,Multiple Myeloma Treatments ,Treatment Options ,Adverse Events ,Drug Sequencing ,Cellular Therapies ,Bi Specifict Cell Engagers ,Cart Therapy ,Cytokine Release Syndrome ,Adverse Event Profiles ,